International Journal of Surgical Pathology · 2009 · 35 citations · 20 references
MedicineOncologyPathologyMetastasisNeoplasiaTumor PathologyColorectal CancerGerm Cell TumorsImmunohistochemistryTesticular CancerTesticular PathologyTumor MorphologyAdenocarcinoma PathologyGerm Cell Tumor HistopathologyGerm Cell Tumor PathologyMetastatic Testicular CancerMixed Germ Cell TumorsTesticular MetastasisTesticular NeoplasmsYolk Sac Tumors
CDX2 has been detected in the majority of colorectal adenocarcinoma cases and may be useful in determining the sites of origin of tumors. In this study, the authors evaluated CDX2 expression in germ cell tumors (GCTs) by immunohistochemistry. Forty cases of testicular GCTs and 8 cases of metastatic GCTs were retrieved for study. In the 40 cases of testicular GCTs, 13 were pure seminomas and 27 mixed GCTs. Yolk sac tumor (YST) was identified by morphology and glypican 3 staining in 20 testicular mixed GCTs. Of these 20 cases, 8 cases showed 1+ positivity for CDX2. Other primitive components of GCTs were negative. For the 6 cases of metastatic mixed GCT with YST, 4 cases were positive, 2+ in 2 cases and 1+ in 2 cases. The positivity of CDX2 in GCTs warrants including YST in the differential diagnosis of adenocarcinoma of unknown origin.
20
The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma
Naoko Yamauchi, Akira Watanabe, Michiyo Hishinuma et al. · Modern Pathology · 2005 · 338 citations · Full text
Medicine, Biochemistry, Oncology +17
Glypican-3 expression is silenced in human breast cancer
Yun‐Yan Xiang, Virginia Ladeda, Jorge Filmus · Oncogene · 2001 · 206 citations
Glypican 3: A Novel Marker in Testicular Germ Cell Tumors
Debra L. Zynger, Nikolay D. Dimov, Chunyan Luan et al. · The American Journal of Surgical Pathology · 2006 · 189 citations
Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer
Edip Uçar, Ersan Semerci, Hasan Üstün et al. · Advances in Therapy · 2008 · 150 citations